Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -80.92% is 32% below its 4-year average of -61.31%, near the high end of its 4-year range (-1492.37%–69.08%).
As of the fiscal period ended Tuesday, June 30, 2026. 689.14% below its 12-month average of -10.25%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -80.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-80.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-10.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-3.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-61.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-142.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-689.14%
CURRENT VS 3Y AVG
-2458.85%
CURRENT VS 5Y AVG
-31.99%
CURRENT VS 10Y AVG
+43.30%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
-140.73%
vs the sector median at left
BioStem Technologies, Inc.
Market Cap
$44.50M
Return on Invested Capital (ROIC)
-80.92%
TTM Avg
-10.25%
3Y Avg
-3.16%
5Y Avg
-61.31%
Market Cap
$45.99M
Return on Invested Capital (ROIC)
-78.42%
TTM Avg
-44.92%
3Y Avg
-51.52%
5Y Avg
-66.63%
Market Cap
$44.50M
Return on Invested Capital (ROIC)
-127.36%
TTM Avg
-34.70%
3Y Avg
-36.91%
5Y Avg
-31.07%
Market Cap
$45.20M
Return on Invested Capital (ROIC)
-156.97%
TTM Avg
-119.62%
3Y Avg
-76.34%
5Y Avg
-59.98%
Market Cap
$43.39M
Return on Invested Capital (ROIC)
-59.93%
TTM Avg
-52.27%
3Y Avg
-45.27%
5Y Avg
-36.51%
Market Cap
$41.92M
Return on Invested Capital (ROIC)
-8.43%
TTM Avg
-19.61%
3Y Avg
-40.73%
5Y Avg
-42.38%
Market Cap
$41.78M
Return on Invested Capital (ROIC)
-72.12%
TTM Avg
-128.00%
3Y Avg
-128.00%
5Y Avg
-128.00%
Market Cap
$48.32M
Return on Invested Capital (ROIC)
-30.75%
TTM Avg
-66.28%
3Y Avg
-31.28%
5Y Avg
-35.56%
Market Cap
$48.32M
Return on Invested Capital (ROIC)
-14.57%
TTM Avg
-26.81%
3Y Avg
-19.60%
5Y Avg
-18.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $44.50M | -80.92% | -10.25% | -3.16% | -61.31% |
| DarioHealth Corp. (DRIO)vs › | $45.99M | -78.42% | -44.92% | -51.52% | -66.63% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.50M | -127.36% | -34.70% | -36.91% | -31.07% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | -156.97% | -119.62% | -76.34% | -59.98% |
| CVRx, Inc. (CVRX)vs › | $43.39M | -59.93% | -52.27% | -45.27% | -36.51% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -8.43% | -19.61% | -40.73% | -42.38% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.78M | -72.12% | -128.00% | -128.00% | -128.00% |
| Lite Strategy, Inc. (LITS)vs › | $48.32M | -30.75% | -66.28% | -31.28% | -35.56% |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.32M | -14.57% | -26.81% | -19.60% | -18.89% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.92M | -66.03% | -39.70% | -29.53% | -27.72% |
ROIC
-80.9%
ROE
-102.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -80.92% |
| 2026-03-31 | -42.46% |
| 2025-12-31 | -1.62% |
| 2025-09-30 | 28.76% |
| 2025-06-30 | 44.96% |
| 2025-03-31 | 61.57% |
| 2024-12-31 | 69.08% |
| 2024-09-30 | 51.20% |
| 2024-06-30 | 33.14% |
| 2024-03-31 | -3.66% |
| 2023-12-31 | -194.86% |
| 2023-09-30 | -295.24% |
| 2023-06-30 | -1492.37% |
| 2023-03-31 | -1160.48% |
| 2022-12-31 | -394.88% |
| 2022-09-30 | -81.90% |
| 2022-06-30 | -64.73% |
| 2022-03-31 | -109.36% |
| 2020-09-30 | -782.36% |
| 2020-06-30 | -293.33% |
| 2020-03-31 | -463.18% |
| 2019-12-31 | -546.30% |
| 2018-12-31 | -220.16% |
| 2018-09-30 | -129.09% |
| 2018-06-30 | -218.96% |
| 2018-03-31 | -216.57% |
| 2017-12-31 | -255.45% |
| 2017-09-30 | -125.04% |
| 2017-06-30 | -77.44% |
| 2017-03-31 | -87.21% |
| 2016-12-31 | -79.72% |
| 2016-09-30 | -352.40% |
| 2016-06-30 | -235.78% |
| 2016-03-31 | -154.22% |
| 2015-12-31 | -110.11% |
| 2015-09-30 | -350.68% |
| 2015-06-30 | -267.92% |
| 2015-03-31 | -103.24% |
| 2014-09-30 | -1520.07% |
| 2014-06-30 | -1261.62% |
